PRCT: PROCEPT BioRobotics Corp.
About
PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. It manufactures and sells the AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating BPH. The firm's proprietary AquaBeam Robotic System employs a single-use disposable handpiece to deliver its Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The company was founded by Nikolai Aljuri and Rodney C. Perkins in 2007 and is headquartered in San Jose, CA.
Current Value
$94.001 Year Return
Current Value
$94.001 Year Return
Key Details
Market Cap
$5.09B
P/E Ratio
-47.93
1Y Stock Return
177.49%
1Y Revenue Growth
71.71%
Dividend Yield
0.00%
Price to Book
20.2
Strategies that include PRCT
Stock's related to PRCT
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| LASR | 38.82% | $526.43M | -2.60% | 0.00% |
| GKOS | 38.15% | $7.95B | +129.45% | 0.00% |
| VCEL | 37.18% | $2.76B | +55.60% | 0.00% |
| PRTA | 36.48% | $756.01M | -56.52% | 0.00% |
| ARR | 36.31% | $1.05B | +8.10% | 16.27% |
| IVR | 35.62% | $495.56M | +2.38% | 19.70% |
| RCKY | 35.29% | $155.86M | -17.74% | 2.95% |
| NCNO | 34.39% | $4.63B | +36.50% | 0.00% |
| RVMD | 34.32% | $9.50B | +171.62% | 0.00% |
| KIDS | 34.14% | $588.93M | -24.59% | 0.00% |
| AUDC | 33.90% | $262.07M | -18.71% | 4.14% |
| KALU | 33.61% | $1.29B | +34.50% | 3.84% |
| INMD | 33.48% | $1.50B | -21.29% | 0.00% |
| TWST | 33.41% | $2.42B | +74.27% | 0.00% |
| TWO | 33.32% | $1.21B | -15.84% | 15.54% |
| PLYM | 33.21% | $842.88M | -11.32% | 5.12% |
| HHH | 32.97% | $3.98B | +14.89% | 0.00% |
| OFIX | 32.87% | $715.75M | +67.38% | 0.00% |
| JOBY | 32.47% | $4.84B | +13.24% | 0.00% |
| RXST | 32.36% | $1.82B | +62.89% | 0.00% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| ZCMD | 0.08% | $2.80M | -88.67% | 0.00% |
| THG | 0.08% | $5.88B | +36.24% | 2.08% |
| SMC | 0.19% | $383.35M | +97.26% | 0.00% |
| CNA | -0.19% | $13.16B | +23.03% | 3.61% |
| AIZ | 0.20% | $11.24B | +33.00% | 1.31% |
| CMTL | 0.22% | $84.44M | -76.16% | 0.00% |
| TRV | -0.28% | $58.86B | +48.10% | 1.59% |
| OCX | -0.36% | $42.93M | -36.09% | 0.00% |
| FENG | 0.42% | $13.37M | +96.77% | 0.00% |
| SOLV | -0.48% | $11.58B | -16.19% | 0.00% |
| CI | -0.50% | $89.70B | +12.57% | 1.68% |
| ADT | 0.53% | $6.85B | +26.68% | 2.64% |
| LUMO | 0.53% | $37.45M | +41.97% | 0.00% |
| BNED | 0.55% | $277.22M | -91.94% | 0.00% |
| BMY | -0.55% | $118.10B | +20.11% | 4.09% |
| SNY | -0.57% | $120.34B | +3.11% | 4.25% |
| BWA | 0.59% | $7.25B | -2.62% | 1.34% |
| SIGI | -0.59% | $5.90B | -4.96% | 1.47% |
| CFLT | 0.60% | $9.28B | +49.05% | 0.00% |
| EIG | 0.61% | $1.30B | +38.83% | 2.25% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| HUSA | -28.31% | $16.69M | -11.56% | 0.00% |
| RNR | -18.01% | $13.74B | +23.09% | 0.58% |
| TPST | -14.99% | $37.75M | -77.59% | 0.00% |
| KDP | -14.66% | $42.76B | -1.22% | 2.77% |
| NOC | -12.87% | $71.54B | +4.23% | 1.60% |
| CPSH | -12.28% | $20.70M | -40.13% | 0.00% |
| RELY | -12.00% | $3.96B | -7.42% | 0.00% |
| CBOE | -11.63% | $21.46B | +15.84% | 1.11% |
| XOM | -11.58% | $521.39B | +13.56% | 3.22% |
| PHG | -11.50% | $24.26B | +27.17% | 0.00% |
| EG | -11.39% | $15.92B | -8.98% | 2.02% |
| GHI | -10.90% | $272.26M | -27.60% | 12.75% |
| COP | -10.46% | $130.16B | -1.63% | 2.59% |
| DOGZ | -10.40% | $614.77M | +1,372.26% | 0.00% |
| OXY | -9.78% | $47.39B | -16.87% | 1.66% |
| PRPO | -9.38% | $9.10M | -13.65% | 0.00% |
| IMO | -9.16% | $39.72B | +31.84% | 2.23% |
| MRO | -9.02% | $16.08B | +13.59% | 1.53% |
| GHG | -8.92% | $180.98M | -36.68% | 0.00% |
| APA | -8.83% | $8.11B | -40.14% | 4.54% |
ETF's related to PRCT
Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| XHE | 46.16% | $213.41M | 0.35% |
| PTH | 44.04% | $143.31M | 0.6% |
| PCEF | 43.45% | $813.14M | 3.08% |
| YYY | 40.13% | $538.03M | 4.6% |
| CWB | 40.09% | $3.94B | 0.4% |
| XT | 39.98% | $3.38B | 0.46% |
| ITEQ | 39.90% | $84.84M | 0.75% |
| WCLD | 39.85% | $454.67M | 0.45% |
| CLOU | 39.70% | $349.39M | 0.68% |
| RSPH | 39.65% | $885.96M | 0.4% |
| ANGL | 39.65% | $3.06B | 0.25% |
| IWR | 39.54% | $39.67B | 0.19% |
| SIZE | 39.25% | $329.63M | 0.15% |
| ARKG | 38.82% | $1.13B | 0.75% |
| VO | 38.67% | $73.70B | 0.04% |
| PBE | 36.90% | $258.53M | 0.58% |
| PRNT | 36.90% | $95.35M | 0.66% |
| BOTZ | 36.83% | $2.57B | 0.68% |
| ARKF | 36.63% | $1.09B | 0.75% |
| ARKK | 36.38% | $6.28B | 0.75% |
Uncorrelated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| KRBN | 0.43% | $242.47M | 0.85% |
| BSCO | 0.74% | $2.35B | 0.1% |
| XHLF | 1.24% | $874.27M | 0.03% |
| YEAR | -1.40% | $1.13B | 0.25% |
| AGZD | 1.82% | $142.76M | 0.23% |
| CANE | 1.95% | $17.72M | 0.29% |
| DBMF | 2.09% | $1.02B | 0.85% |
| JBBB | 2.67% | $1.26B | 0.49% |
| BOXX | 2.73% | $4.43B | 0.1949% |
| FMF | 2.74% | $244.61M | 0.95% |
| IBDP | 2.84% | $2.11B | 0.1% |
| BILZ | 2.90% | $563.02M | 0.14% |
| DBA | -3.34% | $755.88M | 0.93% |
| SHYD | 3.61% | $311.50M | 0.35% |
| SHV | 3.80% | $18.13B | 0.15% |
| CORN | 3.82% | $61.12M | 0.2% |
| CCOR | 3.83% | $109.04M | 1.18% |
| XBIL | 4.01% | $637.70M | 0.15% |
| MINT | 4.27% | $11.62B | 0.35% |
| IAK | 4.48% | $760.79M | 0.39% |
Inversely Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| VIXY | -26.59% | $195.31M | 0.85% |
| BTAL | -24.32% | $388.04M | 1.43% |
| DBO | -20.05% | $217.57M | 0.77% |
| DBE | -19.16% | $50.13M | 0.77% |
| TAIL | -15.92% | $67.98M | 0.59% |
| UUP | -15.28% | $309.25M | 0.77% |
| COMT | -14.65% | $829.06M | 0.48% |
| USCI | -14.45% | $185.47M | 1.07% |
| USDU | -14.25% | $201.97M | 0.5% |
| GSG | -13.45% | $914.42M | 0.75% |
| PDBC | -12.65% | $4.40B | 0.59% |
| DBC | -12.48% | $1.39B | 0.87% |
| CTA | -12.28% | $350.27M | 0.78% |
| TPMN | -11.75% | $40.60M | 0.65% |
| KCCA | -11.69% | $220.51M | 0.87% |
| KMLM | -10.37% | $353.87M | 0.9% |
| EQLS | -7.62% | $76.08M | 1% |
| ULST | -7.13% | $535.47M | 0.2% |
| HDRO | -5.61% | $164.26M | 0.3% |
| HIGH | -5.16% | $302.78M | 0.51% |
News
SeekingAlpha
Baird Small/Mid Cap Growth portfolio increased +6.9% in 3Q, net of fees, compared to the +7.0% increase in our primary benchmark, the Russell 2500 Growth Index.
Yahoo
Does PROCEPT BioRobotics Corporation (PRCT) have what it takes to be a top stock pick for momentum investors? Let's find out.
Yahoo
These leading stocks have given back gains after breaking out of bases. Arista Networks is one of the IBD 50 names deteriorating.
Yahoo
SAN JOSE, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (NASDAQ: PRCT) (“PROCEPT BioRobotics” or the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced the pricing of an underwritten public offering of 1,923,076 shares of its common stock, at a public offering price of $91.00 per share, before underwriting discounts and commissions, for aggregate gross proceeds of approximately
Yahoo
Medical stock Procept BioRobotics has surged past a buy point after third-quarter results beat estimates.
Yahoo
U.S. stocks ended higher on Monday as investors braced for big tech earnings and economic reports. The diminishing geopolitical crisis in the Middle East also boosted investors' sentiment. Israel's limited offense on Iran led to a decline in oil prices.
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.